Follow the 삼일제약 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 삼일제약 has recorded 9 reports. Market capitalisation: €137bn. The latest transaction was filed on 1 June 2026 (Purchase). Among the most active insiders: 허승범. All data is openly available.
9
Insider Decl.
n/a
Thresholds
€39,049
5 ops.
Buy Volume
n/a
2 ops.
Sell Volume
30Σ signal
Buys €39,049n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,613 of 29,062 companies
20.2
score / 100
Value
16
Quality
25
FCF yld-5.3%
Earn yld-26%
EV/EBITDA·
ROE-27%
Gross mgn37%
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.